Literature DB >> 24523059

Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence.

Pierre Danhier1, Géraldine De Preter, Julie Magat, Quentin Godechal, Paolo E Porporato, Bénédicte F Jordan, Olivier Feron, Pierre Sonveaux, Bernard Gallez.   

Abstract

MRI cell tracking is a promising technique for tracking various cell types in living animals. Usually, cells are incubated with iron oxides so that the particles are taken up before the cells are injected in vivo. In the present study, we aimed to monitor migration of luciferase-expressing mouse renal cancer cells (RENCA-luc) after intrarenal or intrasplenic injection. These cells were labelled using Molday Ion Rhodamine B (MIRB) fluorescent superparamagnetic iron oxide particles. Their fate after injection was first assessed using ex vivo X-band electron paramagnetic resonance (EPR) spectroscopy. This biodistribution study showed that RENCA-luc cells quickly colonized the lungs and the liver after intrarenal and intrasplenic injection, respectively. Bioluminescence imaging (BLI) studies confirmed that this cell line preferentially metastasized to these organs. Early tracking of labelled RENCA-luc cells in the liver using high-field MRI (11.7 T) was not feasible because of a lack of sensitivity. MRI of MIRB-labelled RENCA-luc cells after injection in the left kidney was then performed. T2 - and T2 *-weighted images showed that the labelled cells induced hypointense signals at the injection site. Nevertheless, the hypointense regions tended to disappear after several days, mainly owing to dilution of the MIRB iron oxides with cell proliferation. In conclusion, EPR is well adapted to ex vivo analysis of tissues after cell tracking experiments and allows short-term monitoring of metastasizing cells. MRI is a suitable tool for checking labelled cells at their injection site, but dilution of the iron oxides owing to cell division remains a major limitation. BLI remains the most suitable technique for long-term monitoring of metastatic cells.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bioluminescence; cancer; cell tracking; electron paramagnetic resonance; magnetic resonance imaging; metastasis

Mesh:

Substances:

Year:  2014        PMID: 24523059     DOI: 10.1002/cmmi.1553

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  7 in total

1.  The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees.

Authors:  Brittany D Partain; Mythreyi Unni; Carlos Rinaldi; Kyle D Allen
Journal:  J Control Release       Date:  2020-01-28       Impact factor: 9.776

2.  Combining Optical Reporter Proteins with Different Half-lives to Detect Temporal Evolution of Hypoxia and Reoxygenation in Tumors.

Authors:  Pierre Danhier; Balaji Krishnamachary; Santosh Bharti; Samata Kakkad; Yelena Mironchik; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2015-12       Impact factor: 5.715

3.  Multispectral Emissions of Lanthanide-Doped Gadolinium Oxide Nanophosphors for Cathodoluminescence and Near-Infrared Upconversion/Downconversion Imaging.

Authors:  Doan Thi Kim Dung; Shoichiro Fukushima; Taichi Furukawa; Hirohiko Niioka; Takumi Sannomiya; Kaori Kobayashi; Hiroshi Yukawa; Yoshinobu Baba; Mamoru Hashimoto; Jun Miyake
Journal:  Nanomaterials (Basel)       Date:  2016-09-06       Impact factor: 5.076

4.  Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies.

Authors:  Pierre Danhier; Gladys Deumer; Nicolas Joudiou; Caroline Bouzin; Philippe Levêque; Vincent Haufroid; Bénédicte F Jordan; Olivier Feron; Pierre Sonveaux; Bernard Gallez
Journal:  Oncotarget       Date:  2017-06-13

5.  p53 positively regulates the proliferation of hepatic progenitor cells promoted by laminin-521.

Authors:  Mingyang Ma; Shuyao Hua; Xiangde Min; Liang Wang; Jun Li; Ping Wu; Huifang Liang; Bixiang Zhang; Xiaoping Chen; Shuai Xiang
Journal:  Signal Transduct Target Ther       Date:  2022-08-31

6.  Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment.

Authors:  Li Liu; Regan Schuetze; Jeni L Gerberich; Ramona Lopez; Samuel O Odutola; Rajendra P Tanpure; Amanda K Charlton-Sevcik; Justin K Tidmore; Emily A-S Taylor; Payal Kapur; Hans Hammers; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

Review 7.  Iron Oxide as an MRI Contrast Agent for Cell Tracking.

Authors:  Daniel J Korchinski; May Taha; Runze Yang; Nabeela Nathoo; Jeff F Dunn
Journal:  Magn Reson Insights       Date:  2015-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.